Advanced Enzyme Technologies

Sector: Healthcare

Followers

5
5
3
3
.
6
6
1
1
3
3
-3.05 (-0.95%)

As on 04 Nov, 2025 | 10:06

Open Trading A/c
Day Range
316.00
320.40
LH
52 Week Range
257.90
505.70
LH
Volume
* i
Bid / Ask
19,596.00
316.40 / 5.00

Advanced Enzyme Technologies Announcements

Please find enclosed herewith compliance certificate under Regulation 74(5) of SEBI (DP) Regulations, 2018 for quarter ended September 30, 2025.

08 Oct, 2025 | 06:15pm • Source: BSE

Please find enclosed herewith disclosure with respect to the allotment of Equity Shares under the Advanced Enzyme Technologies Limited - Employee Stock Option Scheme 2022.

07 Oct, 2025 | 10:52am • Source: BSE

Please find enclosed herewith the intimation of the trading window closure.

26 Sep, 2025 | 03:34pm • Source: BSE

Please find enclosed herewith Investor Presentation for the Pharma and Healthcare Conference to be held on 23-09-2025.

22 Sep, 2025 | 02:15pm • Source: BSE

Please find enclosed herewith intimation with respect to Pharma and Healthcare conference - by DAM Capital Advisors Limited

19 Sep, 2025 | 06:11pm • Source: BSE

Please find enclosed herewith copy of the newspaper publication with respect to the IEPF 100 Days Campaign - Saksham Niveshak.

11 Sep, 2025 | 05:20pm • Source: BSE

Transcript of the Conference call held on Wednesday, August 06, 2025 with Analysts and Investors for the Un-audited Financial Results of the Company for the...

11 Aug, 2025 | 06:47pm • Source: BSE

Audio recording of Conference Call for the Un-audited Financial Results for the quarter ended June 30, 2025

06 Aug, 2025 | 06:45pm • Source: BSE

Enclosed copy of the newspaper publication of Extract of Un-audited Consolidated Financials Results for the Quarter ended June...

04 Aug, 2025 | 02:32pm • Source: BSE

Appointment of Secretarial Auditors of the Company.

31 Jul, 2025 | 06:38pm • Source: BSE

Please find attached herewith Scrutinizers report and details regarding voting results of the 36th AGM..

31 Jul, 2025 | 06:25pm • Source: BSE

Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform that the...

31 Jul, 2025 | 03:17pm • Source: BSE

Proceedings of the 36th Annual General Meeting (AGM) held on July 30, 2025.

30 Jul, 2025 | 06:20pm • Source: BSE

The Board of Directors of JC Biotech Private Limited (95.72% Subsidiary) at its Meeting held on July 25, 2025, has approved a Collaboration of the...

25 Jul, 2025 | 05:30pm • Source: BSE

Advanced Enzyme Technologies Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 02/08/2025 ,inter alia, to consider...

25 Jul, 2025 | 03:05pm • Source: BSE

Please find attached herewith newspaper publication with respect to special window provided for re-lodgement of Transfer Request of Physical Shares.

18 Jul, 2025 | 05:24pm • Source: BSE

Enclosed copy of the newspaper publication of Notice to Equity Shareholders of the Company regarding transfer of Shares to the Investor Education and Protection Fund...

15 Jul, 2025 | 03:55pm • Source: BSE

With reference to Regulation 74(5) of the Securities and Exchange Board of India (Depositories and Participants) Regulations, 2018, enclosed is the certificate for the quarter...

14 Jul, 2025 | 05:07pm • Source: BSE

Please find enclosed herewith disclosure under Regulation 30 of the SEBI (LODR) Regulations with respect to incorporation of Advanced Nutrazyme Private Limited, a wholly owned...

04 Jul, 2025 | 03:58pm • Source: BSE

Please find enclosed herewith copies of Newspaper publication with respect to the completion of dispatch of Notice and Integrated Annual report for FY 2024-2025.

04 Jul, 2025 | 12:48pm • Source: BSE